Intellectual Property scientific advisor Khushbu Shah co-authored an article titled “Novel Pyrrolo[3,2-d]pyrimidine Compounds Target Mitochondrial and Cytosolic One-carbon Metabolism with Broad-spectrum Antitumor Efficacy” which was published in the October 2019 issue of Molecular Cancer Therapeutics.